One airway, one disease?

Clinical and Experimental Allergy Reviews

Volumn 5, Issue 1, 2005, Pages 16-20

  Fokkens, Wytske J ^a   Braunstahl, G J ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Airway inflammation; Allergen provocation; Co morbid asthma and allergic rhinitis; Eosinophilia; Systemic disease

Indexed keywords

ANTIHISTAMINIC AGENT; BUDESONIDE; CETIRIZINE; CORTICOSTEROID; HISTAMINE H1 RECEPTOR ANTAGONIST; INTERLEUKIN 5; LEVOCETIRIZINE; PLACEBO;

ALLERGIC RHINITIS; ASTHMA; BASOPHIL; BONE MARROW CELL; BRONCHUS HYPERREACTIVITY; BRONCHUS MUCOSA; CELL ACTIVATION; CELL DIFFERENTIATION; CLINICAL TRIAL; COMORBIDITY; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MECHANISM; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HEMATOPOIETIC CELL; HIGH RISK PATIENT; HUMAN; INFLAMMATION; NOSE MUCOSA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROVOCATION TEST; REVIEW; RISK ASSESSMENT; STEM CELL; UPREGULATION;

EID: 22844431518     PISSN: 14729725     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.0077.x     Document Type: Review

References (24)

1. Global Initiative for Asthma Global strategy for asthma management and prevention. 2003; http://www.ginasthma.com/
2. Lundbäck B. Epidemiology of rhinitis and asthma. Clin Exp Allergy 1998; 28 (Suppl. 2):3-10.
3. Salib RJ, Drake-Lee A, Howarth P. Allergic rhinitis: past, present and the future. Clin Otolaryngol 2003; 28:291-303.
4. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003; 58:691-706.
5. Braunstahl G-J, Fokkens W. Nasal involvement in allergic asthma. Allergy 2003; 58:1235-43.
6. Koh YY, Kim CK. The development of asthma in patients with allergic rhinitis. Curr Opin Allergy Clin Immunol 2003; 3:159-64.
7. Guerra S, Sherrill DL, Martinez FD, Barbee RA. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002; 109:419-25.
8. Leynaert B, Neukirch C, Kony S. Association between asthma and rhinitis according to atopic sensitization in a population-based study. J Allergy Clin Immunol 2004; 113:86-93.
9. Verdiani P, Di Carlo S, Baronti A. Different prevalence and degree of non-specific bronchial hyperreactivity between seasonal and perennial rhinitis. J Allergy Clin Immunol 1990; 86:576-82.
10. Prieto JL, Gutiérrez V, Bertó JM, Camps B. Sensitivity and maximal response to methacholine in perennial and seasonal allergic rhinitis. Clin Exp Allergy 1996; 26:61-7.
11. Chakir J, Laviolette M, Turcotte H, Boutet M, Boulet LP. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol 2000; 106:904-10.
12. Braunstahl G-J, Overbeek SE, Klein Jan A, Prins J-B, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol 2001; 107:469-76.
13. Koh YI, Choi IS. Relationship between nasal and bronchial responsiveness in perennial allergic rhinitis patients with asthma. Int Arch Allergy Immunol 2002; 129:341-7.
14. Chanez P, Vignola AM, Vic P et al. Comparison between nasal and bronchial inflammation in asthmatic and control subjects. Am J Respir Crit Care Med 1999; 159:588-95.
15. Gaga M, Lambrou P, Papageorgiou N et al. Eosinophils are a feature of upper and lower airway pathology in non-atopic asthma, irrespective of the presence of rhinitis. Clin Exp Allergy 2000; 30:663-9.
16. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:2051-7.
17. Braunstahl GJ, Overbeek SE, Fokkens WJ et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med 2001; 164:858-65.
18. Saito H, Howie K, Wattie J et al. Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis. Immunol 2001; 104: 226-34.
19. Denburg JA, Sehmi R, Saito H, Pil-Seob J, Inman MD, O'Byrne PM. Systemic aspects of allergic disease: bone marrow responses. J Allergy Clin Immunol 2000; 106:S242-6.
20. Sehmi R, Dorman S, Baatjes A et al. Allergen-induced fluctuation in CC chemokine receptor 3 expression on bone marrow CD34+ cells from asthmatic subjects: significance for mobilization of haemopoietic progenitor cells in allergic inflammation. Immunol 2003; 109:536-46.
21. Aubier M, Neukirch C, Peiffer C, Melac M. Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma. Allergy 2001; 56:35-42.
22. Lee DK, Gray RD, Wilson AM, Robb FM, Soutar PC, Lipworth BJ. Single and short-term dosing effects of levocetirizine on adenosine monophosphate bronchoprovocation in atopic asthma. Br J Clin Pharmacol 2004; 58:34-9.
23. Greiff L, Andersson M, Svensson C et al. Effects of orally inhaled budesonide in seasonal allergic rhinitis. Eur Respir J 1998; 11:1268-73.
24. Bousquet J, van Cauwenberge P, Khaltaev N, ARIA Workshop Group. Allergic Rhinitis and its Impact on Asthma (ARIA). J Allergy Clin Immunol 2001; 108 (Suppl. 5):S147-333.